Biased activation of the receptor tyrosine kinase HER2.

Claudia Catapano, Johanna V Rahm, Marjan Omer, Laura Teodori, Jørgen Kjems, Marina S Dietz, Mike Heilemann

Journal: Cellular and molecular life sciences : CMLS 2023;80(6):158

PMID: 37208479

Abstract

HER2 belongs to the ErbB sub-family of receptor tyrosine kinases and regulates cellular proliferation and growth. Different from other ErbB receptors, HER2 has no known ligand. Activation occurs through heterodimerization with other ErbB receptors and their cognate ligands. This suggests several possible activation paths of HER2 with ligand-specific, differential response, which has so far remained unexplored. Using single-molecule tracking and the diffusion profile of HER2 as a proxy for activity, we measured the activation strength and temporal profile in live cells. We found that HER2 is strongly activated by EGFR-targeting ligands EGF and TGFα, yet with a distinguishable temporal fingerprint. The HER4-targeting ligands EREG and NRGβ1 showed weaker activation of HER2, a preference for EREG, and a delayed response to NRGβ1. Our results indicate a selective ligand response of HER2 that may serve as a regulatory element. Our experimental approach is easily transferable to other membrane receptors targeted by multiple ligands.

© 2023. The Author(s).

Address: Institute of Physical and Theoretical Chemistry, Goethe-University Frankfurt, Max-Von-Laue-Str. 7, 60438, Frankfurt, Germany.; Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark.; Center for Cellular Signal Patterns (CellPAT), Aarhus University, Gustav Wieds Vej 14, 8000, Aarhus C, Denmark.; Institute of Physical and Theoretical Chemistry, Goethe-University Frankfurt, Max-Von-Laue-Str. 7, 60438, Frankfurt, Germany. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.